Aug. 28 - Turmoil at the CDC, narrow COVID approvals and ACIP’s next meeting
CDC panel to discuss COVID, hepatitis B shots in meeting next month; FDA approves updated COVID boosters, but narrows use; Novo strikes RNA drug deal with startup Replicate
HHS is ousting CDC Director Susan Monarez just weeks after her confirmation, although her lawyers say the firing is invalid. Three other top CDC officials resigned in protest.
A federal register notice confirmed dates for the anticipated advisory meeting, which will follow an FDA decision to narrow COVID boosters' approval and comes as CDC leadership is in turmoil.
While the agency cleared vaccines from Pfizer, Moderna and Novavax broadly in older adults, it restricted eligibility in younger people to those with underlying health conditions.
GSK transformed drug development by investing in claims data early, challenging assumptions, and revealing critical treatment dynamics. Learn their approach to securing budget, maximizing ROI, and more in this webinar.
